Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 3rd International Conference on Ophthalmology Thailand.

Submit your Abstract
or e-mail to

Day 1 :

Keynote Forum

Ajay Tripathi

Russells Hall Hospital, UK

Keynote: Orbital inflammation: Myths and the facts

Time : 10:00 - 11:00

OMICS International  World Ophthalmology 2018 International Conference Keynote Speaker Ajay Tripathi photo

Ajay Tripathi has obtained his Masters in Ophthalmology from reputed institution in India and then completed fellowships in Ophthalmology from The Royal College of Physicians and Surgeons of Glasgow, The Royal College of Surgeons Edinburgh and The Royal College of Ophthalmologists, London. He completed his superspeciality fellowships in lid, lacrimal and orbital surgery from University of Leicester and Cambridge University UK. He is working as a consultant in UK since 2007 and is also an Honorary Senior Lecturer in University of Birmingham. He is actively involved in teaching and training programmes within UK, Europe and India. He has a number of research publications in international peer reviewed journals. In addition to his professional commitments, Mr Tripathi is an accomplished singer, actor and writer and he has written many plays, poetries and has directed many plays. He regularly does musical concerts throughout the world to support various charitable organizations.



Aim: Orbital inflammation is an important, yet often misdiagnosed and mismanaged clinical condition. A delayed diagnosis or inappropriate treatment could have a long lasting impact on not only an individual’s vision, but his life as well. In this keynote address it dispels various common myths about orbital inflammation and explains simple facts about the condition.
Method: With review of literature and interesting clinical examples, this will set up a clinical approach for patients suspected to be having orbital inflammation. The role of imaging and some other special investigations is also discussed. The presentation also discusses pitfalls of diagnosis, the role of biopsy, radiotherapy, biological agents etc. A brief mention will also be made about special situation of pediatric orbital inflammation.
Conclusion: It is hoped that the presentation will enhance the understanding about the condition and help to adopt a logical clinical approach for appropriate management of these patients.



Keynote Forum

Sanjoy Chowdhury

Bokaro General Hospital, India

Keynote: Evolution of affordable quality cataract surgery in leprosy: evolution over two decades

Time : 11:20-12:20

OMICS International  World Ophthalmology 2018 International Conference Keynote Speaker Sanjoy Chowdhury photo

Sanjoy Chowdhury is an honors graduate of Calcutta Medical college (MBBS: 1987), who trained in Ophthalmology at the university of Aligarh, receiving postgraduate “diploma “with university Gold Medal (DO:1990) and at the University of Delhi, India to bag the Master’s degree (MS:1993). He is a “Diplomat of National Board of Examinations (1992)” and is a very experienced micro surgeon with special interest in Squint and Community Ophthalmology mainly Leprosy & eye injury. Beyond Eye: Jawhar award, best Innovative manager in 2011 and 2013 of Bokaro steel /SAIL& Best male speaker of AISMOC (SAIL/Bokaro), Joint Director (Medical & health services, SAIL/Bokaro). Head  of ophthalmology department, Bokaro general hospital (ISO certified multispecialty 910 bedded hospital).





Aim:  Our aim is to find out most suitable approach for cataract surgery in leprosy affected people.
Design: Prospective case control study. Cases include cataract surgery in leprosy; non- leprosy people undergoing surgery at Camps are controls (1996-2014).
Methods: Surgical methods include ICCE, ECCE with /or without IOL, Phaco /SICS with IOL
Results: Results were divided into three groups
Group 1: Non IOL cases (1996 to 2000). Vision improved to 6/12 in 120/160 cases in short term.
Group 2: 2005-2009: IOL Cases (phaco & SICS). 210/ 250 cases 210 had more than 6/12. Worse in “cases”with Phaco.
Group 3: 2010 to 2014: SICS with IOL was done in 242 cases. Vision in 235 “cases” >6/12. Results were similar in both PALs and non-leprosy controls.
Conclusion: Long term follow-up reveals SICS with IOL is the best in leprosy. But quality treatment should include all-round care involving different stake holders as this is a mixed problem: “ophthalmo-socio-economic”. More than a lakh new cases/year is huge burden which can be tackled with locally available resources.